Last reviewed · How we verify

NCT07016698

Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)

Recruiting now NA Last updated 17 December 2025
What this trial tests

NA trial testing Rotarex(TM) Rotational Excisional Atherectomy System in Peripheral Arterial Disease(PAD) in 600 participants. Currently enrolling.

Timeline
29 September 2025
Primary endpoint
31 March 2029
31 May 2029

Quick facts

Lead sponsorC. R. Bard
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment600
Start date29 September 2025
Primary completion31 March 2029
Estimated completion31 May 2029
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

C. R. Bard — full company profile →

Who can join

22 and older, any sex, with Peripheral Arterial Disease(PAD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Peripheral Arterial Disease(PAD)

Currently open trials in the same condition.

Other C. R. Bard trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07016698.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing